MedTrace Logo

MI and PreviDent Varnish on Non Cavitated Interproximal Lesions.

NCT03925740 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2020-04-09

No results posted yet for this study

Summary

Fluoride products are proven to be cost effective in preventing dental caries. Newer Fluoride products have been released in the market with different components that may have an impact on the clinical and radiographic outcome regarding incipient caries management. The objective of the study is to compare the effectiveness of PreviDent and MI varnish to (1.23%) Acidulated phosphopeptide Fluoride (APF) on remineralisation of non-cavitated proximal incipient lesions.

Conditions

  • Prevention

Interventions

DRUG

MI Varnish

Application of MI varnish material versus the standard 1.23% APF.

DRUG

PreviDent Varnish

Application of PreviDent Varnish material versus the standard 1.23% APF.

DRUG

1.23% APF

Standard 1.23% APF application

Sponsors & Collaborators

  • King Abdulaziz University

    lead OTHER

Principal Investigators

  • Heba J Sabbagh, PHD · King Abdulaziz University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2020-05-29
Completion
2020-09-01
FDA Drug
Yes

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925740 on ClinicalTrials.gov